Researchers create lab model that could lead to new, non-hormonal birth control methods
Oregon Health & Science University researchers have developed a new lab model to study how changes in cervical mucus during ...
Endocrinology Advisor2 天
Empowering Health Equity: HPV Self-Sampling for Cervical Cancer Prevention in Gender ...
The discrepancy in HPV screening rates emphasizes a need for gender affirming options for sample collections. Considering the susceptibility and infection rate of transmasculine individuals and ...
Pharmaceutical Technology9 天
BAT-8006 by Bio-Thera Solutions for Epithelial Ovarian Cancer: Likelihood of Approval
BAT-8006 is under clinical development by Bio-Thera Solutions and currently in Phase II for Epithelial Ovarian Cancer.
Pharmaceutical Technology9 天
Sacituzumab tirumotecan by Merck for Cervical Cancer: Likelihood of Approval
Sacituzumab tirumotecan is under clinical development by Merck and currently in Phase III for Cervical Cancer.
Targeted Oncology11 天
Novel Therapies and Combinations Lead the Way in Women’s Cancers in 2024
Potential practice-changing therapies in gynecologic cancer include the emergence of carboplatin, paclitaxel, and PD-1 ...
Medscape22 天
Cervical Cancer Screening in Low Resource Settings: Using Visual Inspection With Acetic Acid
Identify the anterior and posterior lip of the cervix, red columnar epithelium, pink squamous epithelium, the squamocolumnar junction, and the transformation zone. Observe all four vaginal ...
Business Standard24 天
Auro Pharma gets UK MHRA nod for cancer drug
Bevacizumab is used in the treatment of various cancers, including metastatic colorectal cancer, recurrent or metastatic non-squamous non-small cell lung cancer, advanced and/or metastatic renal cell ...